Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyTherapeutics Open Access | 10.1172/jci.insight.150079

Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion

Jacob A. Myers,1 Dawn Schirm,1 Laura Bendzick,1 Rachel Hopps,1 Carly Selleck,1 Peter Hinderlie,1 Martin Felices,1 and Jeffrey S. Miller2

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Myers, J. in: JCI | PubMed | Google Scholar

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Schirm, D. in: JCI | PubMed | Google Scholar

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Bendzick, L. in: JCI | PubMed | Google Scholar

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Hopps, R. in: JCI | PubMed | Google Scholar

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Selleck, C. in: JCI | PubMed | Google Scholar

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Hinderlie, P. in: JCI | PubMed | Google Scholar

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Felices, M. in: JCI | PubMed | Google Scholar |

1Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, United States of America

2University of Minnesota, Minneapolis, United States of America

Find articles by Miller, J. in: JCI | PubMed | Google Scholar |

Published June 21, 2022 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.150079.
Copyright © 2022, Myers et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 21, 2022 - Version history
View PDF
Abstract

Natural killer (NK) cell exhaustion is caused by chronic exposure to activating stimuli during viral infection, tumorigenesis, and prolonged cytokine treatment. Evidence suggests that exhaustion may play a role in disease progression, however relative to T cell exhaustion, the mechanisms underlying NK cell exhaustion and methods of reversing it are poorly understood. Here, we describe a novel in vitro model of exhaustion that employs plate-bound agonists of the NK cell activating receptors NKp46 and NKG2D to induce canonical exhaustion phenotypes. In this model, prolonged activation results in downregulation of activating receptors, upregulation of checkpoint markers, decreased cytokine production and cytotoxicity in vitro, defects in glycolytic metabolism, and decreased persistence, function, and tumor control in vivo. Furthermore, we discover a beneficial effect of NK cell inhibitory receptor signaling during exhaustion. By simultaneously engaging the inhibitory receptor NKG2A during activation in our model, cytokine production and cytotoxicity defects can be mitigated, suggesting that balancing positive and negative signals integrated by effector NK cells can be beneficial for anti-tumor immunity. Together, these data uncover some of the mechanisms underlying NK cell exhaustion in humans and establish our novel in vitro model as a valuable tool for studying the processes regulating exhaustion.

Graphical Abstract
graphical abstract
Supplemental material

View Supplemental Figures (1-8) and Table

Version history
  • Version 1 (June 21, 2022): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts